Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)

NCT04004793 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

328

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

BEHAVIORAL: Intensive lifestyle intervention
DRUG: Dapagliflozin 10 MG Oral Tablet
DRUG: Placebo Oral Tablet

Sponsor

Shanghai Zhongshan Hospital